Total Payments
$72,859
2024 Payments
$2,208
Companies
68
Transactions
1,532
Medicare Patients
6,801
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$47,628 (65.4%)
Food & Beverage$24,137 (33.1%)
Travel$745.99 (1.0%)
Consulting$190.00 (0.3%)
Education$158.38 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,628 | 43 | 65.4% |
| Food and Beverage | $24,137 | 1,467 | 33.1% |
| Travel and Lodging | $745.99 | 9 | 1.0% |
| Consulting Fee | $190.00 | 3 | 0.3% |
| Education | $158.38 | 10 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $17,496 | 128 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $15,106 | 80 | $0 (2022) |
| Allergan, Inc. | $10,405 | 116 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $8,285 | 18 | $0 (2021) |
| GENZYME CORPORATION | $1,793 | 57 | $0 (2024) |
| Biogen, Inc. | $1,730 | 80 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $1,685 | 11 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $1,248 | 53 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,167 | 80 | $0 (2024) |
| UCB, Inc. | $1,008 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,208 | 116 | ABBVIE INC. ($496.39) |
| 2023 | $6,833 | 169 | AbbVie Inc. ($4,437) |
| 2022 | $11,001 | 183 | ABBVIE INC. ($7,045) |
| 2021 | $20,259 | 181 | Biohaven Pharmaceuticals, Inc. ($8,267) |
| 2020 | $9,418 | 219 | Allergan, Inc. ($5,980) |
| 2019 | $10,355 | 318 | Sunovion Pharmaceuticals Inc. ($5,523) |
| 2018 | $7,889 | 206 | Sunovion Pharmaceuticals Inc. ($5,243) |
| 2017 | $4,898 | 140 | Sunovion Pharmaceuticals Inc. ($3,301) |
All Payment Transactions
1,532 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: PAIN | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: EPILEPSY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.85 | General |
| Category: Neurology | ||||||
| 12/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: Neurology | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: PAIN | ||||||
| 11/06/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/03/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Neurology | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.21 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Education | In-kind items and services | $18.61 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/18/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/16/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Immunology | ||||||
| 10/16/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,908 | 43,986 | $2.2M | $480,058 |
| 2022 | 20 | 1,842 | 33,313 | $1.9M | $442,343 |
| 2021 | 18 | 1,491 | 26,829 | $1.5M | $365,080 |
| 2020 | 23 | 1,560 | 26,508 | $1.6M | $336,478 |
Total Patients
6,801
Total Services
130,636
Medicare Billing
$1.6M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 85 | 41,319 | $885,053 | $204,187 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 810 | 1,367 | $543,112 | $126,548 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 392 | 392 | $237,262 | $46,827 | 19.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 76 | 193 | $116,848 | $23,944 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 252 | 327 | $89,752 | $21,794 | 24.3% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 49 | 49 | $72,416 | $16,009 | 22.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 82 | 82 | $62,815 | $13,319 | 21.2% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2023 | 39 | 39 | $45,679 | $10,428 | 22.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 12 | 30 | $59,468 | $4,955 | 8.3% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 12 | 24 | $48,572 | $3,889 | 8.0% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 16 | 16 | $15,231 | $3,158 | 20.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 18 | 34 | $9,645 | $2,090 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $6,936 | $1,891 | 27.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $2,139 | $462.55 | 21.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 33 | $1,700 | $329.72 | 19.4% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 29 | 57 | $1,261 | $227.06 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 807 | 1,495 | $593,830 | $150,415 | 25.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 65 | 30,545 | $656,416 | $149,056 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 386 | 386 | $234,020 | $51,418 | 22.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 61 | 161 | $97,474 | $20,710 | 21.2% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2022 | 55 | 55 | $79,950 | $18,649 | 23.3% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2022 | 50 | 50 | $59,330 | $14,106 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 140 | $38,426 | $9,601 | 25.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 48 | 48 | $36,770 | $8,704 | 23.7% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Office | 2022 | 14 | 14 | $17,121 | $3,756 | 21.9% |
About Dr. Noor Yono, M.D
Dr. Noor Yono, M.D is a Clinical Neurophysiology healthcare provider based in Stuart, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1679896526.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Noor Yono, M.D has received a total of $72,859 in payments from pharmaceutical and medical device companies, with $2,208 received in 2024. These payments were reported across 1,532 transactions from 68 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($47,628).
As a Medicare-enrolled provider, Yono has provided services to 6,801 Medicare beneficiaries, totaling 130,636 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Location Stuart, FL
- Active Since 03/07/2010
- Last Updated 09/06/2024
- Taxonomy Code 2084N0600X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679896526
Products in Payments
- UBRELVY (Drug) $21,888
- APTIOM (Drug) $15,001
- NURTEC ODT (Drug) $10,278
- QULIPTA (Drug) $4,291
- SPRIX (Drug) $1,623
- TYSABRI (Biological) $1,221
- BOTOX (Biological) $1,219
- AUBAGIO (Drug) $1,167
- NUPLAZID (Drug) $913.32
- Briviact (Drug) $841.28
- SOLIRIS (Drug) $688.55
- KESIMPTA (Drug) $686.64
- TROKENDI XR (Drug) $469.85
- LEMTRADA (Drug) $420.72
- Xadago (Drug) $337.62
- ULTOMIRIS (Biological) $303.91
- Fycompa (Drug) $293.97
- AJOVY (Biological) $280.98
- ZEPOSIA (Drug) $268.59
- SYMPAZAN (Drug) $265.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.